1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
(
- Contribution to journal › Article
- 2023
-
Mark
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification
(
- Contribution to journal › Article
- 2022
-
Mark
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
(
- Contribution to journal › Article
- 2021
-
Mark
Reduced repetition suppression in aging is driven by tau-related hyperactivity in medial temporal lobe
(
- Contribution to journal › Article
-
Mark
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
(
- Contribution to journal › Article
-
Mark
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease : A Head-to-Head Comparison against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
(
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration : a retrospective diagnostic performance study
(
- Contribution to journal › Article
- 2020
-
Mark
Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults
2020) In European Journal of Nuclear Medicine and Molecular Imaging(
- Contribution to journal › Article
- 2019
-
Mark
Alzheimer's pathology targets distinct memory networks in the ageing brain
(
- Contribution to journal › Article